Pharma could hide adverse drug reaction reports under EU plans, NGOs say
This article was originally published in Scrip
Executive Summary
Eight organisations representing consumers, health insurers, healthcare professionals and NGOs are worried that the European Commission's draft legislative proposals on pharmacovigilance could see pharmaceutical firms take up a bigger role in the collection and interpretation of adverse drug reactions reports (ADRs) with a risk to public health.